Atezolizumab and Bevacizumab in Patients With Recurrent or Metastatic Squamous-cell Carcinoma of the Head and Neck
Clinical trial NCT03818061 · COMPLETED
Trial details
- NCT number
- NCT03818061
- Sponsor
- Centre Leon Berard
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-26
- Primary completion
- 2025-01-15
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.